|
2020
|
Invention
|
Dosing regimen.
The invention provides for a dosing regimen for human antibodies that bind to hu... |
|
2019
|
Invention
|
Combination therapy for soft tissue sarcoma. The present invention provides for use in treating a... |
|
2018
|
Invention
|
Combination therapy for cancer. The present invention provides preparation of medicaments for use... |
|
|
Invention
|
Combination therapy for pancreatic cancer.
The present invention provides for use in treating an... |
|
|
Invention
|
Combination therapy for pancreatic cancer. The present invention provides for use in treating and... |
|
|
Invention
|
Dosing regimen for anti-csf-1r antibody. The invention provides for a dosing regimen for human an... |
|
2017
|
Invention
|
Combination of an anti-vegfr-2 antibody and an anti-pd-l1 antibody for the treatment of cancer.
... |
|
|
Invention
|
Combination of an anti-vegfr-2 antibody and an anti-pd-l1 antibody for the treatment of cancer. T... |
|
|
Invention
|
Combination therapy for cancer.
The present invention provides preparation of medicaments for us... |
|
|
Invention
|
Combination of ramucirumab and pembrolizumab for the treatment of certain cancers. The present di... |
|
2016
|
Invention
|
Combination therapy for cancer.
The present invention relates to a combination of an anti-human ... |
|
|
Invention
|
Combination therapy for cancer. The present invention relates to a combination of an anti-human V... |
|
|
Invention
|
Therapies utilizing compounds to fibroblast growth factor receptor-3 (fgfr3). The invention provi... |
|
2015
|
Invention
|
Therapy for urothelial carcinoma. This invention is directed to the field of cancer treatment, an... |
|
|
Invention
|
Anti-vegfr2 antibody therapy for hepatocellular carcinoma. The invention provides for a human ant... |
|
|
Invention
|
Therapy for gist.
The invention provides for the human antibodies that bind to human platelet-de... |
|
|
Invention
|
Combination therapy.
Combination of human antibodies that bind to human platelet-derived growth ... |
|
|
Invention
|
Therapy for gist. The invention provides for the human antibodies that bind to human platelet-der... |
|
|
Invention
|
Combination therapy. Combination of human antibodies that bind to human platelet-derived growth f... |
|
|
Invention
|
Combination therapy of olaratumab, cardioprotective agent and doxorubicin for the treatment of so... |
|
2014
|
Invention
|
Compounds to fibroblast growth factor receptor-3 (fgfr3) and therapeutic uses. The invention prov... |
|
|
Invention
|
Compounds to fibroblast growth factor receptor-3 (fgfr3) and methods of treatment. The invention ... |
|
|
P/S
|
Medical information services in the field of cancer |
|
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an... |
|
2013
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment ... |
|
|
Invention
|
Anti-vegfr-3 antibody compositions. The present invention provides anti-VEGFR-3 monoclonal antibo... |
|
2012
|
Invention
|
C-kit antibodies and uses thereof. This invention is directed to antibodies that specifically bin... |
|
|
Invention
|
Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment. The present inv... |
|
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention an... |
|
|
Invention
|
Anti-tgf-beta receptor ii antibodies.
The present invention is directed to antibodies against hu... |
|
2011
|
Invention
|
Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof. The present inve... |
|
|
Invention
|
Methods of treating secondary bone tumors with antibodies against pdgfr alpha. The invention prov... |
|
|
Invention
|
Antibodies against pdgfrα to inhibit tumor growth. The invention provides antibodies that bind to... |
|
|
P/S
|
Pharmaceutical preparations, including, pharmaceutical preparations for the diagnosis, prevention... |
|
|
P/S
|
Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Antibodies against vascular endothelial growth factor receptor-1. Monoclonal antibodies that are ... |
|
|
Invention
|
Antibodies against csf-1r. The invention provides a human antibody that binds human CSF-IR with h... |
|
|
Invention
|
Antibodies against csf-1r. The invention provides a human antibody that binds human CSF-1R with h... |
|
2010
|
Invention
|
Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof. The... |
|
|
Invention
|
Anti-flt3 antibodies. The present invention provides fully human antibodies that specifically bin... |
|
2009
|
Invention
|
Anti-flt3 antibodies.
The present invention provides fully human antibodies that specifically bi... |
|
2008
|
P/S
|
Pharmaceutical preparation, namely monoclonal antibody for
the treatment of cancer. |
|
|
Invention
|
Stable antibody formulations.
The present invention provides formulations and methods for the st... |
|
2007
|
P/S
|
Pharmaceutical preparation, namely monoclonal antibody regulating angiogenesis. |
|
2006
|
P/S
|
Pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer.
Pharmaceutica... |
|
|
P/S
|
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER |
|
|
P/S
|
Pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations, namely monoclonal antibody for the treatment of cancer; vaccines.
Ph... |
|
|
P/S
|
Pharmaceutical preparations for treatment of cancer. |
|
2003
|
P/S
|
Pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer. |
|
2001
|
P/S
|
Pharmaceutical preparations for treatment of cancer; vaccines; diagnostic preparations. |
|
|
P/S
|
PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER [ INFORMATION SERVICES RENDERED TO THE PUBLIC... |
|
2000
|
P/S
|
Pharmaceutical preparations, for treatment of cancer. |
|
|
P/S
|
pharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer |
